Conference Coverage of CROI 2022: Clinical Impact of New HIV Data*

Download All
February 13-16, 2022; Virtual
Learn about the latest data on HIV treatment strategies, prevention, and best practices with live webinars, rapid Capsule Summaries, and downloadable slides, and gain global perspectives from companion commentaries and podcasts on key studies from CROI 2022.
Fidelia Bernice, PharmD
Jennifer Cocohoba Headshot
Jennifer Cocohoba, PharmD
Megan Coffee, MD, PhD (DPhil)
Monica Gandhi, MD, MPH
Daniel R. Kuritzkes, MD
Jeffrey Kwong, DNP, MPH, FAANP, FAAN
Susan LeLacheur, DrPH, PA-C, AAHIVS
Babafemi Taiwo, MBBS
David A. Wohl, MD

Clinical Impact of New HIV Data

Listen to expert insights from Fidelia Bernice, PharmD, and Jennifer Cocohoba, PharmD, as they discuss new data presented at CROI 2022, including key findings on investigational options for PrEP, interactions between hormone therapy and PrEP in transgender individuals, impact of anticholinergic drug effects on older PWH, and medication adherence in PWH.

Fidelia Bernice, PharmD Jennifer Cocohoba Headshot Jennifer Cocohoba, PharmD Released: March 15, 2022

Listen to expert insights from Jeffrey Kwong, DNP, MPH, FAANP, FAAN, and Susan LeLacheur, DrPH, PA-C, AAHIVS, as they discuss new data presented at CROI 2022, including key findings on perinatal ART exposure, an investigational formulation for the prevention of pregnancy and HIV, monitoring requirements in LA CAB for PrEP, and myocardial infarction risk in PWH.

Jeffrey Kwong, DNP, MPH, FAANP, FAAN Susan LeLacheur, DrPH, PA-C, AAHIVS Released: March 16, 2022

Hear from CCO’s expert faculty members as they present their insights on some of the most clinically relevant new data presented at CROI 2022, including prevention strategies, long-acting therapies, second-line therapies, comorbidities, and cure.

Daniel R. Kuritzkes, MD David A. Wohl, MD Released: March 3, 2022

Hear from CCO’s expert faculty members as they present their insights on some of the most clinically relevant new data presented at CROI 2022, including prevention strategies, long-acting therapies, second-line therapies, comorbidities, and cure.

Monica Gandhi, MD, MPH Babafemi Taiwo, MBBS Released: March 7, 2022

Read expert faculty members’ summaries of key HIV studies from CROI 2022, including results from studies of prevention strategies, long-acting therapies, second-line therapies, comorbidities, and cure.

Monica Gandhi, MD, MPH Daniel R. Kuritzkes, MD Babafemi Taiwo, MBBS David A. Wohl, MD Released: March 2, 2022

Listen to expert insights from Daniel R. Kuritzkes, MD, and David A. Wohl, MD, on some of the most clinically relevant new data presented at CROI 2022, including prevention strategies, long-acting therapies, second-line therapies, comorbidities, and cure.

Daniel R. Kuritzkes, MD David A. Wohl, MD Released: March 14, 2022

People with HIV are not experiencing the improvement in myocardial infarction risk reduction observed in those without HIV.

David A. Wohl, MD Released: March 16, 2022

Here’s why I think it is important to combine the science and art of medicine to keep patients at the forefront of decision-making for long-acting ART.

Babafemi Taiwo, MBBS Released: March 15, 2022

As shown in studies at CROI 2022 and elsewhere, SARS-CoV-2 diagnostic testing has illuminated gaps in COVID-19 management, highlighting opportunities to address the needs of individuals and the community.

Megan Coffee, MD, PhD (DPhil) Released: June 2, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings